Can a tablet replace hospital visits for blood clot patients?
NCT ID NCT05684770
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looks at whether giving low-risk blood clot patients a 4G tablet for remote check-ups, education, and questionnaires is practical and satisfying for patients and doctors. Fifty participants will use the tablet for up to a year while following standard treatment. The goal is to see if this approach works well and keeps patients safe.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- 4G tablet for remote care
- What this could lead to
- If successful, this could show that remote monitoring is a practical option for managing low-risk blood clots, potentially reducing hospital visits.
- What could go wrong
- This is a small, early feasibility study with only 50 participants, so results may not apply broadly. The tablets might be difficult for some patients to use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THROMBOEMBOLIC DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Hospitalier Eure-Seine
RECRUITINGÉvreux, 27000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Smart patches could save hearts: hospital trial tests continuous monitoring
- New device spots hidden blood clots in real time
- Blood type clues may reveal hidden clot risk
- Blood thinner switch may skew lab results, study warns
- Hospital study aims to find best way to monitor blood thinner dosing
- New study observes best way to treat leg clots without major surgery